Search News
NEWS
Nir Eyal’s research on human challenge trials cited in Congressional letter to HHS and FDA
April 20 2020A paper led by CPLB director Nir Eyal on human challenge trials for a COVID-19 vaccine served as the main piece of evidence underpinning a bipartisan letter sent by 35 members of Congress to the Secretary of Health and Human Services and the Commissioner of the Food and Drug Administration.
Click here to read the full paper at the Journal of Infectious Diseases.
